Healthcare - NORD Pipera Hospital, part of the MedLife Group, marks a national premiere in interventional cardiology for the treatment of atrial fibrillation through ...
HAYWARD, Calif., March 12, 2026--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond ...
Pulse Biosciences, Inc. , developer of the novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced first patient ...
Abbott (NYSE: ABT), a global healthcare leader, today announced results from the FreeDM2 randomized controlled trial (RCT) showing that ...